Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mimica

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Lijecnicki Vjesnik|April 5, 2002
[Diagnostic and therapeutic guidelines (algorithms) in the treatment of schizophrenia. Recommendations of the Croatian Society for Clinical Psychiatry of the Croatian Medical Association]S S Strkalj Ivezić, V F Smalc, N Mimica, et al.
Revista Clinica Espanola|February 26, 2015
Hyperandrogenism secondary to Leydig ovarian tumorS Herranz-Antolín, N Mimica-Haasz, C Marcuello-Foncillas, et al.
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Lijecnicki Vjesnik|April 5, 2002
[Diagnostic and therapeutic guidelines (algorithms) in the treatment of schizophrenia. Recommendations of the Croatian Society for Clinical Psychiatry of the Croatian Medical Association]S S Strkalj Ivezić, V F Smalc, N Mimica, et al.
Revista Clinica Espanola|February 26, 2015
Hyperandrogenism secondary to Leydig ovarian tumorS Herranz-Antolín, N Mimica-Haasz, C Marcuello-Foncillas, et al.
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
Pageof 3